Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          HHS Search block
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations Breadcrumb
    Home
                              Blog
                              President Biden’s Lower Cost Prescription Drug Law is Promoting Women’s Economic Security
 Navigate to:
  Categories
    Coronavirus (12)
        Health IT (13)
        Fraud (1)
        Grants and Contracts (1)
        Research (5)
        Prevention and Wellness (21)
        Health Data (6)
        Holidays and Observances (17)
        Global Health (4)
        Public Health and Safety (28)
        HIPAA (4)
        Programs for Families and Children (6)
        Americans with Disabilities Act (1)
        Mental Health and Substance Abuse (1)
        Vaccines (1)
        HHS Administrative (4)
        LGBT (1)
        Emergency Preparedness and Response (1)
        Drug Pricing (5)Text resize icon

                    




President Biden’s Lower Cost Prescription Drug Law is Promoting Women’s Economic Security








  
  
    

  
      
**May 15, 2024**
                |
        By:  Stacy    Sanders, Chief Competition Officer, HHS

  
**Summary:**
  





President Biden's prescription law is lowering health care costs for women who are seniors and women under the age of 65 with disabilities with Medicare


      Bringing Savings to Real People
Imagine facing the daily challenges of managing your chronic condition, and then discovering that the medication vital to your well-being is priced beyond reach. You grapple with the constant burden of paying for your medication, often sacrificing necessities for you and your loved ones. Just when you manage to stabilize your finances, the medication's cost skyrockets, ballooning by almost 50% since you began relying on it, now tallying up to a staggering $10,000 annually, and you see no help in sight.Because of stories like this, President Biden passed the Inflation Reduction Act, offering relief with high prescription drug costs to millions of Americans. This story is not a hypothetical. It’s Samantha Reid’s reality. National Women’s Health Week (NWHW) is a perfect time to highlight how the President’s lower cost prescription drug law is helping women afford their prescription drugs.Samantha’s story underscores why the Inflation Reduction Act is so significant for women. Among people with Medicare, women have disproportionately higher rates of some health conditions, including Alzheimer’s disease, asthma, fibromyalgia, osteoporosis, and certain types of cancer, which can lead to high prescription drug costs. The President’s law is providing relief now for women with Medicare by capping out-of-pocket drug costs, requiring drug companies to pay a rebate to Medicare if they raise drug prices faster than inflation, and providing additional savings to those eligible for Medicare’s Extra Help program.In 2020, about 733,000 women enrolled in Medicare Part D and Part B would have benefited from the Inflation Reduction Act’s $35 per month cap on out-of-pocket costs for Medicare-covered insulin products. Women with Medicare paid approximately $133.4 million in out-of-pocket costs for Part D covered vaccines, averaging about $68 per enrollee in 2021. Those women would not have paid anything out of pocket for recommended vaccines covered under Part D if the Inflation Reduction Act vaccine provision had been in effect in 2021. Thanks to newly expanded eligibility for the Extra Help program, about 857,000 women who likely meet the requirements for the program but are not yet enrolled are projected to save $1,000 or more in 2025. These provisions highlight the Act's significant impact in promoting women's health and financial well-being.The Inflation Reduction Act represents a significant step forward in ensuring equitable access to affordable health care. As we observe National Women’s Health Week, a week dedicated to empowering women to take charge of their health journeys and spotlighting health issues unique to women, let’s recognize how President Biden’s new prescription drug law promotes women’s economic security. Learn more about how the Inflation Reduction Act is benefiting women here and for more information on the Inflation Reduction Act and Medicare, visit LowerDrugCosts.gov.
  Posted In:
  Drug PricingSign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases

Sign Up







  Subscribe to RSS
    

      Receive latest updates

                    
  


Related Blog Posts
    

      Two Years of Lower Prescription Drug Costs
  

Martha’s Story: Capping Medicare Out-of-Pocket Prescription Drug Costs
  

Putting Money Back in the Pockets of Seniors with Medicare in Nevada Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility Statement
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​ Disclaimer Policy: Links with this icon () mean that you are leaving the HHS website. The Department of Health and Human Services (HHS) cannot guarantee the accuracy of a non-federal website.
                  Linking to a non-federal website does not mean that HHS or its employees endorse the sponsors, information, or products presented on the website. HHS links outside of itself to provide you with further information.
                  You will be bound by the destination website's privacy policy and/or terms of service when you follow the link.
                  HHS is not responsible for Section 508 compliance (accessibility) on private websites. For more information on HHS's web notification policies, see Website Disclaimers.
 Continue
                  Go back